Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,198 total articles
Generac's new long-term supply agreement with a major hyperscaler includes $2.4B of initial deliveries in 2027-2028 and a data-center backlog of $1.6B. That incremental demand materially reshapes revenue visibility and could justify a re-rating. This trade plan buys the re-rating while protecting downside with a firm stop.
AMD looks positioned to capture share and margin tailwinds after Intel raised server pricing. Fundamentals remain strong: market cap roughly $913B, free cash flow of $8.4B, and a clean balance sheet (debt/equity ~0.05). Valuation is rich, so this is a tactical mid-term trade that leverages secular AI/data-center demand and recent technical momentum…
Blackstone (BX) is trading well below its 52‑week high, yielding north of 4% and showing improving fundamentals in free cash flow and enterprise value metrics. We recommend a mid‑term long swing: entry $125.50, target $145.00, stop $115.00. The trade leans on compelling yield, flow/capital‑raising tailwinds for alternatives, and an attractive EV/EB…
Sumitomo Mitsui Financial Group (SMFG) trades at a reasonable P/E of 15.1 and a PB of 1.68. With a $168 billion market cap, a near-2% yield, and signs of buying interest tied to corporate unwind activity, the ADR offers a favorable mid-term trade: entry $26.75, target $29.50, stop $25.25 over a 45 trading-day horizon.
Nano Labs (NA) is a micro-cap Web3/AI infrastructure play trading at a market cap of ~$51.7M. The stock has been punished by a 66% revenue drop and a RMB316.7M (US$46.5M) H1 2026 loss driven by mark-to-market BNB losses, yet management retains 70,000 BNB and is pushing AI hardware (iPollo Claw) and North America partnerships. Technicals show improv…
Nano Labs (NA) is a micro-cap semiconductor and AI-infrastructure play that has seen steep swings this year. H1 2026 results expose cash-flow pain from crypto exposure, but a 70,000 BNB reserve, CEO insider buying and new AI hardware initiatives create a credible path to recovery. This trade idea recommends a controlled long position at $2.30 with …
Progyny is a leader in employer-sponsored fertility benefits with record recent revenues, strong free cash flow, and a healthy balance sheet. With guidance that already implies resilience after losing a large client and new product distribution into small employers, the stock offers asymmetric upside vs. downside risk over a 180 trading day horizon…
Nano Labs (NA) is a sub-$60M market-cap semiconductor/Web3 hybrid that has been hammered by crypto markdowns but is pushing into AI hardware with the iPollo ClawPC A1 Mini and a North America AI infrastructure MOU. Technical momentum and high short interest create a tactical long opportunity: entry $2.30, target $4.00, stop $1.70 for a mid-term (45…
ExxonMobil ($XOM) is a deep-pocketed integrated major trading near $162 with a $682.6B market cap, attractive yield, and technical breadth that supports a disciplined long trade. This idea targets near-term outperformance driven by earnings upside, higher oil prices and a potential re-rating tied to underappreciated international upstream projects.…
Tamarack Valley Energy (TVE) offers a tradeable asymmetric setup: upside if upstream execution and a firmer oil price beat tepid sentiment, with defined downside that can be capped with a tight stop. We outline a mid-term trade plan, the fundamental drivers that should matter to investors, and the key catalysts and risks to monitor.
Otis fell roughly 22% from its 52-week high into a recent low near $67.64. The sell-off looks overdone relative to the company's recurring service cash flows, a 5% dividend raise, and valuation metrics that are reasonable for a capital-intensive industrial with stable demand. This trade idea lays out an exact entry, stop, and target for a mid-term …
Schr f6dinger (SDGR) is a two-legged company: established software sales that generate recurring, high-margin revenue and an increasingly credible drug-discovery engine. With a $2.11B market cap, improving technical momentum and a large biosimulation market tailwind, SDGR is a constructive mid-term trade. Entry at $28.17, stop $22.00, target $36.00…
Halliburton is a leveraged way to play a multi-year shift: producers are increasingly turning to more technically complex, higher-cost resources, which favors large integrated oilfield-services providers. We lay out a trade with defined entry, stop and target and a 180-trading-day horizon, driven by improving backlog, pricing power on complex proje…
Meta is trading near $675 after a strong run; fundamentals (free cash flow $40.976B, ROE ~26%) and fresh MTIA processor rollout news make a pre-ex-dividend long a pragmatic trade. Entry ahead of the 09/21/2026 ex-dividend can capture both the $0.525 distribution and near-term upside toward the 52-week high, while technicals and a clear stop limit d…
BlackRock Science & Technology Trust (BST) offers a 6.34% reported yield, deep tech equity exposure and a valuation that looks inexpensive on headline multiples. This trade targets income today with upside if AI names or a pre-IPO stake like Anthropic reprice. Plan: buy $48.04, stop $44.00, target $53.50 over a mid-term window tied to corporate dis…
Viridian (VRDN) is being valued like a commercial-stage autoimmune franchise despite negative trial headlines earlier this year. Market cap sits near $2.52B and enterprise value at $2.73B while free cash flow remains deeply negative. If management can translate two product launches into visible revenue growth and upgrade guidance, VRDN could re-rat…
Intel is reporting rapid AI and foundry momentum and headline catalysts (SK Hynix talks) have driven the stock to $110.74 and a $585B market cap. That growth is real, but the market is pricing near-parity with winners while fundamentals still show negative EPS, weak returns and stretched cashflow multiples. This trade idea sizes a mid-term short wi…
Caris Life Sciences (CRIS) is a differentiated molecular diagnostics company focused on comprehensive tumor profiling and data-driven therapeutic insights. We think current levels underprice the company’s commercial runway, margin expansion potential, and optionality from its real-world evidence assets. Trade idea: initiate a long position with a $…
Palantir is demonstrating widening optionality as its software platforms become the operational backbone for governments and enterprises adopting AI. Revenue and earnings are accelerating, cash generation is real, and key technicals support a measured long entry at current levels. Valuation is rich, so this is a conviction trade with a strict stop …
Par Pacific (PARR) looks set to tack on another leg higher. The stock trades at an attractive valuation (EV/EBITDA ~3.96; P/E ~4.95) against strong cash generation and high ROE. A modest re-rating toward peer multiples plus continued healthy refining margins is enough to push the stock to $100 in the mid term. This trade idea lays out an entry, sto…
Broadcom is a high-quality, cash-generative semiconductor and software conglomerate trading at a premium multiple. The company’s scale in AI chips and infrastructure software gives it asymmetric upside if management’s aggressive AI revenue targets are realized. Given current technicals and valuation, this is a buy for disciplined, long-term traders…
WGXRF is trading at $3.92 after a pullback below its short-term moving averages. With RSI around 41 and MACD signaling bearish momentum, the technical picture looks cautious. That said, persistent elevated short interest (1.85M shares as of 08/31/2026) and recent volume patterns create a setup where confirmation that management has cut capital spen…
B2Gold (BTG) is not the distressed bargain some hoped for after a July low, but the stock offers an asymmetric trade: limited near-term upside from upside gold moves and meaningful upside if Fekola Regional and Goose recover to planned output. We recommend a measured buy at $5.36 with a $6.28 target and a $4.40 stop, sized for a mid-term (45 tradin…
Nokia is showing concrete commercial progress on AI-native network products and expanding capacity to capture growing carrier demand. At a market cap near $60.9B and a current price around $10.56, the risk/reward favors a mid-term long if recent AI-RAN wins convert and supply constraints ease.
Oracle’s headline-grabbing debt figures and elevated capex forecasts have created outsized fear in the tape. The underlying business - a fast-growing cloud infrastructure franchise and profitable software flywheel - still supports a constructive view. This trade idea lays out a mid-term (45 trading days) long entry with clear stop and target, backe…
